President, Boston Healthcare Associates, Inc.
Mr. Ferrara has over 18 years of experience in life sciences consulting, working with biopharmaceutical, medical device, diagnostics, and health care IT clients in market and business development strategy. He leads the global consulting team with practice areas in reimbursement and pricing, health economics, market analysis, and business development strategy. Mr. Ferrara has extensive experience in the development of novel business approaches designed to capture evidence-based value for innovation health care technologies. Mr. Ferrara writes and speaks extensively on the subject of the value of medical technology innovation, with particular focus on pharmacogenomics, specialty pharmaceuticals, and novel therapeutic devices. Prior to his consulting role, Mr. Ferrara led a joint venture between Boston Healthcare and a non-profit research organization focused on a global electronic medical record network for the purposes of clinical trials and health outcomes research. Mr. Ferrara completed undergraduate studies at the University of Cincinnati and received a master’s degree from Harvard University.
Session Abstract – PMWC 2018 Silicon Valley
Session Synopsis: A tremendous amount of work and effort is put into FDA approval of a drug, yet often the necessary accompanying diagnostics are not in place to meet the needs in a timely fashion. Upstream processes, such as tighter collaborations between pharma and diagnostics companies, more robust and earlier assay development, better transition of translational insight into clinical applications, or clinical trial design itself need to be optimized. This session’s dialogue will focus on these aspects and how a critical diagnostics component can be optimally integrated into a commercial strategy to create a more efficient and successful approval and commercialization process.